News Image

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Provided By GlobeNewswire

Last update: Sep 11, 2024

FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara’s joint venture partner InfuSystem Holdings, Inc., announced today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (“ChemoMouthpiece”).

Read more at globenewswire.com

SANARA MEDTECH INC

NASDAQ:SMTI (8/15/2025, 8:00:02 PM)

After market: 29.43 -0.25 (-0.84%)

29.68

-0.72 (-2.37%)



Find more stocks in the Stock Screener

SMTI Latest News and Analysis

Follow ChartMill for more